Showing results (151-160 of 8,878) with videos related to
Sort By:
Pageof 888
Schizophrenia Research|March 27, 2012
Treatment response after relapse in a placebo-controlled maintenance trial in schizophreniaRobin Emsley, Isaac Nuamah, David Hough, et al.Schizophrenia Research|January 24, 2012
Cognitive adaptation training combined with assertive community treatment: a randomised longitudinal trialJens Peter Hansen, Birte Østergaard, Merete Nordentoft, et al.Schizophrenia Research|January 24, 2012
Regional differences in expression of β-tubulin isoforms in schizophreniaMark S Moehle, Richard F Luduena, Vahram Haroutunian, et al.Schizophrenia Research|April 10, 2012
A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorderMark Weiser, Ari A Gershon, Katya Rubinstein, et al.Schizophrenia Research|April 7, 2012
Hippocampal novelty activations in schizophrenia: disease and medication effectsCarol A Tamminga, Binu P Thomas, Ronald Chin, et al.Schizophrenia Research|March 27, 2012
Niacin subsensitivity is associated with functional impairment in schizophreniaErik MessamoreSchizophrenia Research|April 3, 2012
Training of affect recognition (TAR) in schizophrenia--impact on functional outcomeG Sachs, B Winklbaur, R Jagsch, et al.Schizophrenia Research|April 5, 2011
Functional resting-state networks are differentially affected in schizophreniaNeil D Woodward, Baxter Rogers, Stephan HeckersSchizophrenia Research|April 5, 2011
Characteristics and predictors of long-term institutionalization in patients with schizophreniaPeter Uggerby, René Ernst Nielsen, Christoph U Correll, et al.Schizophrenia Research|April 5, 2011
Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT studyGemma Safont, Iluminada Corripio, María J Escartí, et al.Pageof 888